Biomillenia
Biomillenia uses unrivaled technology from the research of the world's leading institutes of genomics and microfluidics with the aim of creating a new characteristic production of strains and enzymes with the aim of sustainable development of green chemistry products.
We harness the power of natural selection with unrivaled screening speed and throughput based on microfluidics technology, thus we master the main blockage for innovative production and development of strains and enzymes.
Single cell culture and high-throughput screening capable of detecting 100 million different strains in just 3 days has become a reality, offering unparalleled speed in the development of non-GMO and GMO production strains. We focus on high-value chemicals to make manufacturing sustainable and environmentally friendly but also to reduce production costs, quality and specificity by focusing particularly on non-GMO methods. Whether for our own production or for the development of partnership projects, our productivity, speed and cost reduction for alternative product development is our main asset.
Original laboratories / Establishments: Harvard, Broad Institute, ESPCI Paris - PSL
Director: Dirk Loeffert
